Should You Buy Johnson & Johnson Before It Splits?

The world's largest healthcare company is about to get a little smaller. Recently, Johnson & Johnson (NYSE: JNJ) told investors it would spin off its consumer health business into a separate new company.

If you've been considering this dividend-paying stock for one reason or another, the impending spinoff isn't anything to worry about. In fact, it makes the stock significantly more attractive. Here's a closer look at the company's plans so you can see why.

Image source: Getty Images.

Source Fool.com